Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma

Giulia Pintarelli, Alice Dassano, Chiara E. Cotroneo, Antonella Galvan, Sara Noci, Rocco Piazza, Alessandra Pirola, R. Spinelli, Matteo Alessio Incarbone, Alessandro Palleschi, Lorenzo Paolo Rosso, Luigi Santambrogio, Tommaso A. Dragani, Francesca Colombo

Research output: Contribution to journalArticle

Abstract

Read-through transcripts result from the continuous transcription of adjacent, similarly oriented genes, with the splicing out of the intergenic region. They have been found in several neoplastic and normal tissues, but their pathophysiological significance is unclear. We used high-throughput sequencing of cDNA fragments (RNA-Seq) to identify read-through transcripts in the non-involved lung tissue of 64 surgically treated lung adenocarcinoma patients. A total of 52 distinct read-through species was identified, with 24 patients having at least one read-through event, up to a maximum of 17 such transcripts in one patient. Sanger sequencing validated 28 of these transcripts and identified an additional 15, for a total of 43 distinct read-through events involving 35 gene pairs. Expression levels of 10 validated read-through transcripts were measured by quantitative PCR in pairs of matched non-involved lung tissue and lung adenocarcinoma tissue from 45 patients. Higher expression levels were observed in normal lung tissue than in the tumor counterpart, with median relative quantification ratios between normal and tumor varying from 1.90 to 7.78; the difference was statistically significant (P <0.001, Wilcoxon's signed-rank test for paired samples) for eight transcripts: ELAVL1-TIMM44, FAM162B-ZUFSP, IFNAR2-IL10RB, INMT-FAM188B, KIAA1841-C2orf74, NFATC3-PLA2G15, SIRPB1-SIRPD, and SHANK3-ACR. This report documents the presence of read-through transcripts in apparently normal lung tissue, with inter-individual differences in patterns and abundance. It also shows their down-regulation in tumors, suggesting that these chimeric transcripts may function as tumor suppressors in lung tissue.

Original languageEnglish
Pages (from-to)27889-27898
Number of pages10
JournalOncotarget
Volume7
Issue number19
DOIs
Publication statusPublished - May 10 2016

Fingerprint

Lung
Neoplasms
Intergenic DNA
Nonparametric Statistics
Adenocarcinoma of lung
Individuality
Genes
Down-Regulation
Complementary DNA
RNA
Polymerase Chain Reaction

Keywords

  • Conjoined genes
  • Gene fusion
  • Lung adenocarcinoma
  • Read-through transcripts
  • RNA-Seq

ASJC Scopus subject areas

  • Oncology

Cite this

Pintarelli, G., Dassano, A., Cotroneo, C. E., Galvan, A., Noci, S., Piazza, R., ... Colombo, F. (2016). Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma. Oncotarget, 7(19), 27889-27898. https://doi.org/10.18632/oncotarget.8556

Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma. / Pintarelli, Giulia; Dassano, Alice; Cotroneo, Chiara E.; Galvan, Antonella; Noci, Sara; Piazza, Rocco; Pirola, Alessandra; Spinelli, R.; Incarbone, Matteo Alessio; Palleschi, Alessandro; Rosso, Lorenzo Paolo; Santambrogio, Luigi; Dragani, Tommaso A.; Colombo, Francesca.

In: Oncotarget, Vol. 7, No. 19, 10.05.2016, p. 27889-27898.

Research output: Contribution to journalArticle

Pintarelli, Giulia ; Dassano, Alice ; Cotroneo, Chiara E. ; Galvan, Antonella ; Noci, Sara ; Piazza, Rocco ; Pirola, Alessandra ; Spinelli, R. ; Incarbone, Matteo Alessio ; Palleschi, Alessandro ; Rosso, Lorenzo Paolo ; Santambrogio, Luigi ; Dragani, Tommaso A. ; Colombo, Francesca. / Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma. In: Oncotarget. 2016 ; Vol. 7, No. 19. pp. 27889-27898.
@article{65f40456d927479a94a4bab04eba80b9,
title = "Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma",
abstract = "Read-through transcripts result from the continuous transcription of adjacent, similarly oriented genes, with the splicing out of the intergenic region. They have been found in several neoplastic and normal tissues, but their pathophysiological significance is unclear. We used high-throughput sequencing of cDNA fragments (RNA-Seq) to identify read-through transcripts in the non-involved lung tissue of 64 surgically treated lung adenocarcinoma patients. A total of 52 distinct read-through species was identified, with 24 patients having at least one read-through event, up to a maximum of 17 such transcripts in one patient. Sanger sequencing validated 28 of these transcripts and identified an additional 15, for a total of 43 distinct read-through events involving 35 gene pairs. Expression levels of 10 validated read-through transcripts were measured by quantitative PCR in pairs of matched non-involved lung tissue and lung adenocarcinoma tissue from 45 patients. Higher expression levels were observed in normal lung tissue than in the tumor counterpart, with median relative quantification ratios between normal and tumor varying from 1.90 to 7.78; the difference was statistically significant (P <0.001, Wilcoxon's signed-rank test for paired samples) for eight transcripts: ELAVL1-TIMM44, FAM162B-ZUFSP, IFNAR2-IL10RB, INMT-FAM188B, KIAA1841-C2orf74, NFATC3-PLA2G15, SIRPB1-SIRPD, and SHANK3-ACR. This report documents the presence of read-through transcripts in apparently normal lung tissue, with inter-individual differences in patterns and abundance. It also shows their down-regulation in tumors, suggesting that these chimeric transcripts may function as tumor suppressors in lung tissue.",
keywords = "Conjoined genes, Gene fusion, Lung adenocarcinoma, Read-through transcripts, RNA-Seq",
author = "Giulia Pintarelli and Alice Dassano and Cotroneo, {Chiara E.} and Antonella Galvan and Sara Noci and Rocco Piazza and Alessandra Pirola and R. Spinelli and Incarbone, {Matteo Alessio} and Alessandro Palleschi and Rosso, {Lorenzo Paolo} and Luigi Santambrogio and Dragani, {Tommaso A.} and Francesca Colombo",
year = "2016",
month = "5",
day = "10",
doi = "10.18632/oncotarget.8556",
language = "English",
volume = "7",
pages = "27889--27898",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "19",

}

TY - JOUR

T1 - Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma

AU - Pintarelli, Giulia

AU - Dassano, Alice

AU - Cotroneo, Chiara E.

AU - Galvan, Antonella

AU - Noci, Sara

AU - Piazza, Rocco

AU - Pirola, Alessandra

AU - Spinelli, R.

AU - Incarbone, Matteo Alessio

AU - Palleschi, Alessandro

AU - Rosso, Lorenzo Paolo

AU - Santambrogio, Luigi

AU - Dragani, Tommaso A.

AU - Colombo, Francesca

PY - 2016/5/10

Y1 - 2016/5/10

N2 - Read-through transcripts result from the continuous transcription of adjacent, similarly oriented genes, with the splicing out of the intergenic region. They have been found in several neoplastic and normal tissues, but their pathophysiological significance is unclear. We used high-throughput sequencing of cDNA fragments (RNA-Seq) to identify read-through transcripts in the non-involved lung tissue of 64 surgically treated lung adenocarcinoma patients. A total of 52 distinct read-through species was identified, with 24 patients having at least one read-through event, up to a maximum of 17 such transcripts in one patient. Sanger sequencing validated 28 of these transcripts and identified an additional 15, for a total of 43 distinct read-through events involving 35 gene pairs. Expression levels of 10 validated read-through transcripts were measured by quantitative PCR in pairs of matched non-involved lung tissue and lung adenocarcinoma tissue from 45 patients. Higher expression levels were observed in normal lung tissue than in the tumor counterpart, with median relative quantification ratios between normal and tumor varying from 1.90 to 7.78; the difference was statistically significant (P <0.001, Wilcoxon's signed-rank test for paired samples) for eight transcripts: ELAVL1-TIMM44, FAM162B-ZUFSP, IFNAR2-IL10RB, INMT-FAM188B, KIAA1841-C2orf74, NFATC3-PLA2G15, SIRPB1-SIRPD, and SHANK3-ACR. This report documents the presence of read-through transcripts in apparently normal lung tissue, with inter-individual differences in patterns and abundance. It also shows their down-regulation in tumors, suggesting that these chimeric transcripts may function as tumor suppressors in lung tissue.

AB - Read-through transcripts result from the continuous transcription of adjacent, similarly oriented genes, with the splicing out of the intergenic region. They have been found in several neoplastic and normal tissues, but their pathophysiological significance is unclear. We used high-throughput sequencing of cDNA fragments (RNA-Seq) to identify read-through transcripts in the non-involved lung tissue of 64 surgically treated lung adenocarcinoma patients. A total of 52 distinct read-through species was identified, with 24 patients having at least one read-through event, up to a maximum of 17 such transcripts in one patient. Sanger sequencing validated 28 of these transcripts and identified an additional 15, for a total of 43 distinct read-through events involving 35 gene pairs. Expression levels of 10 validated read-through transcripts were measured by quantitative PCR in pairs of matched non-involved lung tissue and lung adenocarcinoma tissue from 45 patients. Higher expression levels were observed in normal lung tissue than in the tumor counterpart, with median relative quantification ratios between normal and tumor varying from 1.90 to 7.78; the difference was statistically significant (P <0.001, Wilcoxon's signed-rank test for paired samples) for eight transcripts: ELAVL1-TIMM44, FAM162B-ZUFSP, IFNAR2-IL10RB, INMT-FAM188B, KIAA1841-C2orf74, NFATC3-PLA2G15, SIRPB1-SIRPD, and SHANK3-ACR. This report documents the presence of read-through transcripts in apparently normal lung tissue, with inter-individual differences in patterns and abundance. It also shows their down-regulation in tumors, suggesting that these chimeric transcripts may function as tumor suppressors in lung tissue.

KW - Conjoined genes

KW - Gene fusion

KW - Lung adenocarcinoma

KW - Read-through transcripts

KW - RNA-Seq

UR - http://www.scopus.com/inward/record.url?scp=84968861323&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84968861323&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.8556

DO - 10.18632/oncotarget.8556

M3 - Article

VL - 7

SP - 27889

EP - 27898

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 19

ER -